Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term IN-VIVO. Found 32 abstracts

no pagination
de Bono JS, Piulats JM, Pandha HS, Petrylak DP, Saad F, Aparicio LM, Sandhu SK, Fong P, Gillessen S, Hudes GR, Wang T, Scranton J, Pollak MN. Phase II Randomized Study of Figitumumab plus Docetaxel and Docetaxel Alone with Crossover for Metastatic Castration-Resistant Prostate Cancer. Clinical Cancer Research. 2014 Apr;20(7):1925-34.   PMCID: No NIH funds
Kong WM, Li HB, Tuma RF, Ganea D. Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS. Cell Immunol. 2014 Jan;287(1):1-17.
Lu CT, Zhao YZ, Wong HL, Cai J, Peng L, Tian XQ. Current approaches to enhance CNS delivery of drugs across the brain barriers. Int J Nanomed. 2014 Jan;9:2241-56.
Allen JD, Jaffer ZM, Park SJ, Burgin S, Hofmann C, Sells MA, Chen S, Derr-Yellin E, Michels EG, McDaniel A, Bessler WK, Ingram DA, Atkinson SJ, Travers JB, Chernoff J, Clapp DW. p21-activated kinase regulates mast cell degranulation via effects on calcium mobilization and cytoskeletal dynamics. Blood. 2009 Mar;113(12):2695-705.
Banumathy G, Somaiah N, Zhang RG, Tang Y, Hoffmann J, Andrake M, Ceulemans H, Schultz D, Marmorstein R, Adams PD. Human UBN1 Is an Ortholog of Yeast Hpc2p and Has an Essential Role in the HIRA/ASF1a Chromatin-Remodeling Pathway in Senescent Cells. Molecular and Cellular Biology. 2009 Feb;29(3):758-70.   PMCID: PMC2630694
Gollmer K, Asperti-Boursin F, Tanaka Y, Okkenhaug K, Vanhaesebroeck B, Peterson JR, Fukui Y, Donnadieu E, Stein JV. CCL21 mediates CD4(+) T-cell costimulation via a DOCK2/Rac-dependent pathway. Blood. 2009 Jul;114(3):580-8.   PMCID: PMC2713469
Xu M, Sharma A, Hossain MZ, Wiest DL, Sen JM. Sustained Expression of Pre-TCR Induced beta-Catenin in Post-beta-Selection Thymocytes Blocks T Cell Development. Journal of Immunology. 2009 Jan;182(2):759-65.   PMCID: PMC 2701226
Yu JJ, Robb VA, Morrison TA, Ariazi EA, Karbowniczek M, Astrinidis A, Wang C, Hernandez-Cuebas L, Seeholzer LF, Nicolas E, Hensley H, Jordan VC, Walker CL, Henske EP. Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells. Proceedings of the National Academy of Sciences of the United States of America. 2009 Feb;106(8):2635-40.   PMCID: PMC 2637277
Zhang M, Ho A, Hammond EH, Suzuki Y, Bermudez RS, Lee RJ, Pilepich M, Shipley WU, Sandler H, Khor LY, Pollack A, Chakravarti A. Prognostic value of surviving in locally advanced prostate cancer: study based on RTOG 8610. International Journal of Radiation Oncology Biology Physics. 2009 Mar;73(4):1033-42.   PMCID: PMC 2678565
Chang JH, Cruo JT, Jiang D, Guo HT, Taylor JM, Block TM. Liver-specific MicroRNA miR-122 enhances the replication of hepatitis C virus in nonhepatic cells. Journal of Virology. 2008 Aug;82(16):8215-23.
Gururajan M, Simmons A, Dasu T, Spear BT, Calulot C, Robertson DA, Wiest DL, Monroe JG, Bondada S. Early growth response genes regulate B cell development, proliferation, and immune response. Journal of Immunology. 2008 Oct;181(7):4590-602.
Han HJ, Russo J, Kohwi Y, Kohwi-Shigematsu T. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature. 2008 Mar;452(7184):187-U36.
Horiguchi A, Chen DY, Goodman OB, Zheng R, Shen R, Guan H, Hersh LB, Nanus DM. Neutral endopeptidase inhibits prostate cancer tumorigenesis by reducing FGF-2-mediated angiogenesis. Prostate Cancer and Prostatic Diseases. 2008 Mar;11(1):79-87.
Lu ML, Strohecker A, Chen F, Kwan T, Bosman J, Jordan VC, Cryns VL. Aspirin sensitizes cancer cells to TRAIL-Induced apoptosis by reducing surviving levels. Clinical Cancer Research. 2008 May;14(10):3168-76.
Rothweiler U, Czarna A, Krajewski M, Ciombor J, Kalinski C, Khazak V, Ross G, Skobeleva N, Weber L, Holak TA. Isoquinolin-1-one inhibitors of the MDM2-p53 interaction. ChemMedChem. 2008 Jul;3(7):1118-28.
Zaret KS, Grompe M. Generation and Regeneration of Cells of the Liver and Pancreas. Science (New York, NY). 2008 Dec;322(5907):1490-4.
Anderson SJ, Lauritsen JP, Hartman MG, Foushee AM, Lefebvre JM, Shinton SA, Gerhardt B, Hard RR, Oravecz T, Wiest DL. Ablation of ribosomal protein L22 selectively impairs alpha beta T cell development by activation of a p53-dependent checkpoint. Immunity. 2007 Jun;26(6):759-72.
Beckman RA, Weiner LM, Davis HM. Antibody constructs in cancer therapy - Protein engineering strategies to improve exposure in solid tumors. Cancer. 2007 Jan;109(2):170-9.
Berencsi K, Meropol NJ, Hoffman JP, Sigurdson E, Giles L, Rani P, Somasundaram R, Zhang TQ, Kalabis J, Caputo L, Furth E, Swoboda R, Marincola F, Herlyn D. Colon carcinoma cells induce CXCL11-dependent migration of CXCR3-expressing cytotoxic T lymphocytes in organotypic culture. Cancer Immunology Immunotherapy. 2007 Mar;56(3):359-70.
Chai N, Chang HE, Nicolas E, Gudima S, Chang JH, Taylor J. Assembly of hepatitis B virus envelope proteins onto a lentivirus pseudotype that infects primary human hepatocytes. Journal of Virology. 2007 Oct;81(20):10897-904.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term IN-VIVO

IN-VIVO EXPRESSION RECEPTOR DENDRITIC CELLS GROWTH-FACTOR RECEPTOR DIFFERENTIATION CENTRAL-NERVOUS-SYSTEM INSULIN ACTIVATION TUMOR-GROWTH APOPTOSIS PROGRESSION SUBGENOMIC REPLICONS RESPONSES Chemokines MACROPHAGE DIFFERENTIATION MDM2 compound design-NMR screening-p53-protein-protein interactions PAK1 FIBROBLAST INTERACTIONS TRANSLOCATION IGF-IR BINDING PROTEIN SIGNAL-TRANSDUCTION GROWTH-FACTOR CANCER PATIENTS CELL-MIGRATION RECEPTOR SIGNALS SOLID TUMORS EGR TRANSCRIPTION FACTORS lentivirus RECEPTORS drug delivery system SURVIVIN ONCOGENE-INDUCED SENESCENCE SOLID LIPID NANOPARTICLES AGONIST SMALL-MOLECULE INHIBITORS HISTONE GENE-TRANSCRIPTION BREAST-CANCER MEDIATED APOPTOSIS IMMEDIATE-EARLY GENE EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS TARGETING PROPERTIES TUMORICIDAL ACTIVITY T-CELLS NGFI-A VASCULAR FUNCTION BETA-CELLS OPEN-LABEL PHARMACOKINETIC MODEL CHROMATIN Cell Biology HUMAN MONOCLONAL-ANTIBODY P53 PATHWAY ANTIGEN CANCER METASTASIS NONSTEROIDAL ANTIINFLAMMATORY DRUGS MONOCLONAL-ANTIBODY Gp1a blood-brain barrier (BBB) NUCLEOSOME ASSEMBLY PATHWAYS DNA-REPLICATION MODULATION Survivin PREMATURE SENESCENCE apoptosis DEFINITIVE P53 PROSTATE-CANCER BLOOD-BRAIN SUBCUTANEOUS TUMORS LIGAND-INDUCED APOPTOSIS tumor immunity HEPATIC SPECIFICATION INCREASED SURVIVAL basic fibroblast growth factor Prostate cancer MESSENGER-RNA LYMPHOCYTES SCLEROSIS COMPLEX VECTORS ANTI-APOPTOSIS GENE MICROTUBULE NUDE-MICE Oncology INTERFERON ROR-GAMMA-T CELL-PROLIFERATION cerebrospinal fluid (CSF) MAMMALIAN TARGET GASTRIC CARCINOMAS CHAIN SURVIVAL PROMOTER EPITHELIAL PROGENITOR CELLS HEPATOCELLULAR-CARCINOMA CANNABINOID PEPTIDES chemokines CANCER GENE DELIVERY Prognostic factor RNA AUTOREGULATORY FEEDBACK LOOP PHOSPHORYLATION CXC-CHEMOKINE HYPERTENSION SACCHAROMYCES-CEREVISIAE PHOSPHOINOSITIDE 3-KINASE chemotaxis VESICULAR STOMATITIS-VIRUS P53-MDM2 INTERACTION ISOQUINOLONIC ACIDS INHIBITION SPLICE VARIANTS central nervous system CHAIN GENE REARRANGEMENT BREAST-CANCER CELLS TUMOR SUPPRESSION PREDNISONE DELTA-VIRUS LYMPHANGIOLEIOMYOMATOSIS CONJUGATED NANOPARTICLES MECHANISM MURINE LYMPHOCYTES-B SV40-DERIVED VECTORS LENTIVIRAL VECTORS DIRECT SUPPRESSION TISSUE DISTRIBUTION angiogenesis RECEPTOR-INDUCED APOPTOSIS HUMAN T-LYMPHOCYTES Immunology INTERSTITIAL CEREBROSPINAL-FLUID HETEROCHROMATIN FOCI TRANSMEMBRANE TOPOLOGY B-RAF KINASE MULTIPLE-SCLEROSIS WEST-NILE-VIRUS FIBROBLAST GROWTH FACTOR-2 GENE GENE-TRANSFER MULTICELL SPHEROIDS TRANSDUCTION SINGLE-CHAIN FV PATHWAY ACTIVATION TRANSGENIC MICE HOMOPHTHALIC ANHYDRIDE Radiotherapy
Last updated on Wednesday, March 04, 2020